A Study to Evaluate the Efficacy and Safety of Lumacaftor in Combination With Ivacaftor in Subjects With CF, Homozygous for the F508del-CFTR Mutation
Clinical trial NCT02514473 · COMPLETED
Trial details
- NCT number
- NCT02514473
- Sponsor
- Vertex Pharmaceuticals Incorporated
- Status
- COMPLETED
- Phase
- Phase 3
- Study type
- INTERVENTIONAL
- Start date
- 2015-07-01
- Primary completion
- 2016-09-01
- Enrollment
- 206
Track trials programmatically
Sponsors, conditions and status changes through the Atlas API.